Pulmonary Endogenous Fluorescence Allows the Distinction of Primary Lung Cancer from the Perilesional Lung Parenchyma
Open Access
- 5 August 2015
- journal article
- clinical trial
- Published by Public Library of Science (PLoS) in PLOS ONE
- Vol. 10 (8), e0134559
- https://doi.org/10.1371/journal.pone.0134559
Abstract
Pre-therapeutic pathological diagnosis is a crucial step of the management of pulmonary nodules suspected of being non small cell lung cancer (NSCLC), especially in the frame of currently implemented lung cancer screening programs in high-risk patients. Based on a human ex vivo model, we hypothesized that an embedded device measuring endogenous fluorescence would be able to distinguish pulmonary malignant lesions from the perilesional lung tissue. Consecutive patients who underwent surgical resection of pulmonary lesions were included in this prospective and observational study over an 8-month period. Measurements were performed back table on surgical specimens in the operative room, both on suspicious lesions and the perilesional healthy parenchyma. Endogenous fluorescence signal was characterized according to three criteria: maximal intensity (Imax), wavelength, and shape of the signal (missing, stable, instable, photobleaching). Ninety-six patients with 111 suspicious lesions were included. Final pathological diagnoses were: primary lung cancers (n = 60), lung metastases of extra-thoracic malignancies (n = 27) and non-tumoral lesions (n = 24). Mean Imax was significantly higher in NSCLC targeted lesions when compared to the perilesional lung parenchyma (p<0,0001) or non-tumoral lesions (p<0,0001). Similarly, photobleaching was more frequently found in NSCLC than in perilesional lung (p<0,0001), or in non-tumoral lesions (p<0,001). Respective associated wavelengths were not statistically different between perilesional lung and either primary lung cancers or non-tumoral lesions. Considering lung metastases, both mean Imax and wavelength of the targeted lesions were not different from those of the perilesional lung tissue. In contrast, photobleaching was significantly more frequently observed in the targeted lesions than in the perilesional lung (p≤0,01). Our results demonstrate that endogenous fluorescence applied to the diagnosis of lung nodules allows distinguishing NSCLC from the surrounding healthy parenchyma and from non-tumoral lesions. Inconclusive results were found for lung metastases due to the heterogeneity of this population.This publication has 26 references indexed in Scilit:
- Intraoperative Imaging-Guided Cancer Surgery: From Current Fluorescence Molecular Imaging Methods to Future Multi-Modality Imaging TechnologyTheranostics, 2014
- Photodynamic therapy for intractable bronchial lung cancerPhotodiagnosis and Photodynamic Therapy, 2013
- Identification of metastatic nodal disease in a phase 1 dose-escalation trial of intraoperative sentinel lymph node mapping in non–small cell lung cancer using near-infrared imagingThe Journal of Thoracic and Cardiovascular Surgery, 2013
- Probability of Cancer in Pulmonary Nodules Detected on First Screening CTThe New England Journal of Medicine, 2013
- Results of Initial Low-Dose Computed Tomographic Screening for Lung CancerThe New England Journal of Medicine, 2013
- Diagnosis and Treatment of Bronchial Intraepithelial Neoplasia and Early Lung Cancer of the Central AirwaysSocial psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2013
- Evaluation of Individuals With Pulmonary Nodules: When Is It Lung Cancer?Social psychiatry. Sozialpsychiatrie. Psychiatrie sociale, 2013
- Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012European Journal of Cancer, 2013
- Image-Guided Sentinel Lymph Node Mapping and Nanotechnology-Based Nodal Treatment in Lung Cancer Using Invisible Near-Infrared Fluorescent LightSeminars in Thoracic and Cardiovascular Surgery, 2010
- Fluorescence Spectroscopy of Neoplastic and Non-Neoplastic TissuesNeoplasia, 2000